Yield10 Bioscience, Inc. Forecast, price target & analysts
Yield10 Bioscience, Inc. Target price 2024 - Analyst rating & recommendation
Yield10 Bioscience, Inc. Classifications & Recommendation:
Yield10 Bioscience, Inc. Price Target
| Target Price | $2.50 |
| Price | $1.08 |
| Potential |
131.48%
register free of charge
|
| Number of Estimates | 1 |
|
1 Analyst has issued a Yield10 Bioscience, Inc. price target 2025.
The average Yield10 Bioscience, Inc. target price is $2.50.
This is
131.48%
register free of charge
|
|
| A rating was issued by 2 analysts: 0 Analysts recommend Yield10 Bioscience, Inc. to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Yield10 Bioscience, Inc. stock has an average upside potential 2025 of
131.48%
register free of charge
|
Sales and Margin forecast 2024, 2025 & 2026
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Revenue Million $ | 0.06 | 1.20 |
| 86.67% | 1,900.00% | |
| EBITDA Margin | -23,550.00% | -761.17% |
| 727.93% | 96.77% | |
| Net Margin | -46,570.67% | -574.93% |
| 11,764.13% | 98.77% |
1 Analyst has issued a sales forecast Yield10 Bioscience, Inc. 2024 . The average Yield10 Bioscience, Inc. sales estimate is
This results in the following potential growth metrics:
1 Analyst has issued an EBITDA forecast Yield10 Bioscience, Inc. 2024 . The average Yield10 Bioscience, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
1 Analyst has issued a net profit forecast Yield10 Bioscience, Inc. 2024 . The average Yield10 Bioscience, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 & 2026
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -43.66 | -10.78 |
| 1,481.88% | 75.31% | |
| P/E | negative | |
| EV/Sales | 2.36 |
1 Analysts have issued a Yield10 Bioscience, Inc. forecast for earnings per share. The average Yield10 Bioscience, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Yield10 Bioscience, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Yield10 Bioscience, Inc....
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
